project id: TCGA-GBM; case submitter id: TCGA-RR-A6KA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 7.3; age at index: 72; days to birth: -26582; days to death: 191; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1940; year of death: 2012; age at diagnosis: 26582; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C71.1; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Frontal lobe; synchronous malignancy: No; tissue or organ of origin: Frontal lobe; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 282; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-RR-A6KA-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 50.0; percent tumor cells: 40.0; percent tumor nuclei: 80.0;